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CORTICOTROPIN-RELEASING HORMONE EXPRESSION IN THE
IMMATURE RAT
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Department of Anatomy & Neurobiology and Pediatrics, University of California, Irvine, CA
92697-4475, USA
Abstract
Corticotropin-releasing hormone, a major neuromodulator of the neuroendocrine stress response,
is expressed in the immature hippocampus, where it enhances glutamate receptor-mediated
excitation of principal cells. Since the peptide influences hippocampal synaptic efficacy, its
secretion from peptidergic interneuronal terminals may augment hippocampal-mediated functions
such as learning and memory. However, whereas information regarding the regulation of
corticotropin-releasing hormone’s abundance in CNS regions involved with the neuroendocrine
responses to stress has been forthcoming, the mechanisms regulating the peptide’s levels in the
hippocampus have not yet been determined. Here we tested the hypothesis that, in the immature
rat hippocampus, neuronal stimulation, rather than neuroendocrine challenge, influences the
peptide’s expression. Messenger RNA levels of corticotropin-releasing hormone in hippocampal
CA1, CA3 and the dentate gyrus, as well as in the hypothalamic paraventricular nucleus, were
determined after cold, a physiological challenge that activates the hypothalamic pituitary adrenal
system in immature rats, and after activation of hippocampal neurons by hyperthermia. These
studies demonstrated that, while cold challenge enhanced corticotropin-releasing hormone
messenger RNA levels in the hypothalamus, hippocampal expression of this neuropeptide was
unchanged. Secondly, hyperthermia stimulated expression of hippocampal immediate-early genes,
as well as of corticotropin-releasing hormone. Finally, the mechanism of hippocampal
corticotropin-releasing hormone induction required neuronal stimulation and was abolished by
barbiturate administration.
Taken together, these results indicate that neuronal stimulation may regulate hippocampal
corticotropin-releasing hormone expression in the immature rat, whereas the peptide’s expression
in the hypothalamus is influenced by neuroendocrine challenges.
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Corticotropin-releasing hormone (CRH) is a peptide with both neuroendocrine and
neurotransmitter properties.57 The neuroendocrine effects of CRH, the key mediator of the
stress response, originate from clusters of peptidergic cells in the hypothalamic
paraventricular nucleus (PVN).24,34 CRH also functions as a neuromodulator in a number of
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limbic and autonomic brain circuits.21,22,24,43 CRH-producing neurons are widely but
specifically distributed in the brain,49 including a substantial CRH-expressing neuronal
population located in the central nucleus of the amygdala (ACe),22,53 a region considered as
a major source for extra-endocrine CRH-mediated neurotransmission.24
Abundant target neurons for CRH, expressing cognate receptors, have been demonstrated in
the hippocampus.2,13,15 In addition, physiological effects of CRH on hippocampal neurons
have been found, including facilitation of memory retention and increased protein
phosphorylation.10,33 Conversely, abnormalities of CRH-mediated limbic neurotransmission
may contribute to neurological disorders such as depression43 or Alzheimer’s disease.10,33
The source of endogenous CRH that may act on hippocampal CRH receptors has been a
focus of investigation. Scattered CRH-immunoreactive neurons had been described in the
hippocampal formation,41,48,53 and recent double-labeling and ultrastructural studies have
demonstrated a robust population of CRH-expressing GABAergic interneurons in the
hippocampal formation of non-stressed developing rats.59 A subpopulation of these neurons,
co-expressing parvalbumin, has been identified as basket and chandelier cells.59 Axon
terminals of these CRH-immunoreactive interneurons, synapsing on cell bodies of
hippocampal principal neurons, are thus strategically positioned to influence
neurotransmission in the hippocampal circuit via release of both CRH and GABA.59
In addition, it has been demonstrated in both the mature and developing hippocampus that
application of CRH may lead to excessive excitation of the hippocampal circuit, resulting in
repetitive discharges of hippocampal neurons in vitro1,25,50 and in seizures in vivo.7,39 It has
been suggested that excessive elevation of hippocampal CRH levels may contribute to
abnormal neuronal excitation (seizures).6 Thus, regulation of CRH levels in peptidergic
hippocampal neurons may be important for both normal and pathological activation of the
hippocampal circuit,6,25,50 predicting that these levels may be subject to tight physiological
control. However, the regulation of CRH expression in the hippocampus has not been
elucidated. In the PVN and the ACe, transcription of the CRH gene is enhanced by stress
(defined operationally as activation of the neuroendocrine hypothalamic–pituitary–adrenal
axis), leading to increased steady-state levels of CRH mRNA.30,35,60 Concurrent with
induction of CRH transcription in these regions, stress leads to robust expression of
immediate-early genes,26,30,45 indicating general activation of the involved neurons.31,42
Whether CRH gene expression in the hippocampus is influenced by challenges that activate
the neuroendocrine hypothalamic–pituitary–adrenal axis, or by physiological stimulation of
hippocampal neurons (evident from electrophysiological, behavioral and molecular
measures), has not been resolved. Here, we investigated the influence of two physiological
stimuli (cold and hyperthermia) on immature rat hippocampal and hypothalamic CRH
mRNA levels, demonstrating signal- and region-specific up-regulation of CRH expression.
CRH mRNA induction correlated with c-fos expression, suggesting that activation of
discrete signal-transduction pathways may be required for physiological signals to influence
hippocampal CRH expression.
EXPERIMENTAL PROCEDURES
Animals and tissue preparation
Immature rats were used in this study for two reasons: (i) previous work from this laboratory
has characterized hippocampal and hypothalamic CRH expression during this age,59,60 and
(ii) hippocampal CRH expression may be particularly robust during the second postnatal
week in the rat59 (and Chen et al., unpublished observations). Ten-day-old rats of both
genders used in this study were offspring of timed pregnancy Sprague–Dawley-derived
dams (Zivic-Miller, Zelienople, PA). Animals were maintained in NIH-approved facilities
on a 12-h/12-h light–dark cycle with access to unlimited lab chow and water. Cages were
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monitored every 12 h for the presence of pups and the date of birth was considered as day 0.
Litters were culled to 12 pups and mixed among experimental groups (n = 4–6 per group per
experiment). When tissues were required for both immunocytochemistry and in situ
hybridization, the experiments were repeated. Thus, effects of experimental manipulations
were compared among litter-mates. Potential diurnal variability was addressed by initiating
all experiments between 8.00 a.m. and 10.00 a.m., and cages were undisturbed for 24 h prior
to initiation of experiments. All experimental procedures conformed to NIH guidelines. All
efforts were made to minimize the number of animals used and their suffering.
To avoid potential confounders of different durations of separation from the mother on the
animals’ stress response, both laboratory controls and experimental groups were subjected to
the same duration (2–4 h) of maternal separation, and animals killed at later time-points
were returned to home cages. Plasma corticosterone was measured for stress-free and
laboratory controls, and at the end of hyperthermia or cold challenge using
radioimmunoassay (ICN, Irvine, CA).23,60 Assay sensitivity was 0.1 μg/dl; interassay
variability was 10–16%. Tissues were processed by one of two methods. For in situ
hybridization (ISH), rapid decapitation preceded brain dissection on to powdered dry ice.
Brains were stored at −80°C, and serial coronal sections (20 μm) were cut from the anterior
commissure–medial preoptic region through to the level of the habenula (A 4.5 to A 1.2
mm) in the 10-day-old rat. Every 10th section was stained for neuroanatomical localization
purposes; sections were stored at −80°C. For immunocytochemistry (ICC), animals were
perfused under terminal anesthesia (pentobarbital, 100 mg/kg). Brains were cryoprotected
and cut into 20-μm sections using a cryotome.
Experimental design
The overall strategy was to test the differential effects of two physiological stimuli on
neuronal activation (measured by immediate-early gene expression, behavior and
hippocampal electrophysiology) and on CRH gene expression in major fields of the
hippocampal formation, compared with expression of these genes in the PVN, the key
neuroendocrine stress-control region. Cold exposure was selected as a well-characterized
physiological stimulus that activates the neuroendocrine hypothalamic–pituitary–adrenal
axis in the immature rat.23,60 Cold stress has been shown to lead to release of CRH from
PVN neurons60 and to up-regulation of CRH mRNA expression in the PVN.60
Hyperthermia was chosen as a stimulus known to induce hippocampal neuronal stimulation
in the immature rodent,5,18,56 shown in previous behavioral and electrophysiological
studies.5,14,18 CRH mRNA levels were determined using ISH to generate a systematic
spatio-temporal analysis of CRH gene activation, whereas induction of the immediate-early
gene c-fos was measured using both ISH and ICC.
The cold challenge paradigm—This followed previously established protocols.3,23,60
In brief, immature rats (n = 6 for ISH analysis, n = 4 for ICC) were separated from the
mother and subjected to maximally tolerated cold exposure, defined by development of rigor
and diminished response to tactile stimulus. Maximum exposure required 40–50 min at 4°C
and resulted in an average rectal temperature of 11°C.23,60 Following cold exposure, pups
were placed on a euthermic pad and regained normal core temperature (33–34°C) in 10–15
min.
Hyperthermia induction—This has been described in detail elsewhere.5,14,18,56 In brief,
the core temperature of immature rats (n = 42) was raised using a regulated stream of
moderately heated air, aiming for, ~41°C (as during high fever). Rectal temperatures were
measured at baseline and at 2-min intervals. Hyperthermia stimulates hippocampal neurons,
leading to electrophysiological and behavioral seizures.5,14,18,56 Behavioral seizures were
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monitored in all animals and, for correlating behavioral and electrophysiological activation,
electrodes were implanted on the day prior to the experiment in a separate group of rats, as
described below. Following the hyperthermia period, animals were placed on a cool surface
for 30 min, hydrated orally and returned to home cages. Those who were sedated due to
pentobarbital pretreatment were hydrated orally and returned to their cages when their
behavior normalized (typically <1 h). Hyperthermia (>39.5°C) was maintained for 27–28
min (Table 1).
Controls—Two groups of controls were used. “Stress-free” animals (n = 6, used for ISH)
were killed within 45 s of disturbance;23,59 “lab controls” (n = 5 for ISH, n = 4 for ICC)
were kept in the laboratory, separated from their mothers for the same duration as the
experimental groups, under normothermic conditions (core temperature 33–34°C). The
groups differed in plasma corticosterone levels (Table 3), but not in CRH mRNA levels or
their (negligible) c-fos expression.
Elimination of hyperthermia-induced neuronal stimulation
To determine whether CRH gene expression required hippocampal neuronal activation, an
experimental group was subjected to hyperthermia in the presence of the short-acting
barbiturate, pentobarbital, that disrupts polysynaptic neurotransmission via interaction with
the GABAA receptor. Behavioral measures of hippocampal activation (seizures) were
abolished by pentobarbital in all animals. To ascertain elimination of electrophysiological
parameters of hyperthermia-induced neuronal stimulation, hippocampal
electroencephalograms (EEGs) were obtained in both pentobarbital-pretreated and naive
rats. In brief, one day prior to experiments, immature rats (n = 6) were implanted with
bipolar electrodes directed at the dorsal hippocampus, using methods and coordinates
described in detail previously.4,7,9,18 After a 24-h recuperation period, hippocampal EEGs
were obtained in the presence or absence of pentobarbital (30 mg/kg, i.p.), both before and
subsequent to induction of hyperthermia. Recordings were obtained from freely moving
animals, using long flexible wires, as described elsewhere.7,9 Electrode placement was
verified in all animals.
In situ hybridization histochemistry for c-fos and corticotropin-releasing hormone
messenger RNAs
ISH was performed as described previously for oligonucleotide probes8,23,60 or cRNA
probes.19,20 In brief, 20-μm coronal sections were collected on gelatin-coated slides and
stored at −80°C. Sections were thawed, air-dried, fixed in paraformaldehyde, dehydrated
and rehydrated through graded ethanols, exposed to 0.25% acetic anhydride in 0.1 M
triethanolamine (pH 8) and dehydrated. Pre-hybridization (1 h) and hybridization steps were
performed in a humidified chamber in a solution of 50% formamide, 5 × SET, 0.2% sodium
dodecyl sulfate, 5 × Denhardt’s, 0.5 mg/ml salmon sperm DNA, 0.25 mg/ml yeast tRNA,
100 mM dithiothreitol and 10% dextran sulfate. Following pre-hybridization, sections were
hybridized overnight. For detection of CRH mRNA, sections were incubated at 40°C and the
hybridization buffer included a deoxy-oligonucleotide probe complementary to the coding
region of CRH mRNA and 3′ end-labeled with [35S]dATP as described previously.8,60 Post-
hybridization, sections were washed, most stringently at 0.03 × standard saline citrate). For
detection of c-fos mRNA, sections were hybridized at 55°C with 1 × 106 c.p.m. of 35S-
labeled ribonucleotide probe complementary to c-fos mRNA.16 After hybridization, sections
were digested with 200 μg/ml RNase A (Calbiochem, La Jolla, CA) for 30 min at 37°C.
Sections underwent serial washes of increasing stringency at 55°C, the most stringent at 0.03
× standard saline citrate for 1 h.19,20 Hybridized sections were apposed to film (Hyperfilm
βMax, Amersham, IL) for seven to 14 days. Selected sections were also dipped in emulsion
(NTB-2, Eastman Kodak, Rochester, NY) and exposed for four to six weeks.
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Acquisition and quantitative analysis of in situ hybridization signal
Semi-quantitative analysis of CRH mRNA was performed following ISH, as described
previously.19,23 Digitized images of each brain section were acquired using a StudioStar
scanner (AGFA, resolution 1200 × 1200 dots per inch) and analysed using the ImageTool
software program (University of Texas Health Science Center, San Antonio, TX, version
1.25). Densities were calibrated using 14C standards and are expressed in μCi/g after
correcting for background by subtracting the density of the hybridization signal over the
corpus callosum. All analyses were carried out without knowledge of treatment group.
Initially, 20 coronal sections of the anterior (septal) and mid hippocampus, A 2.6 to A 2.0
mm in reference to bregma,50 were analysed. To optimize neuroanatomical matching and to
minimize inter-ISH and inter-animal variability of background signal, the 10 best sections
for each animal, based on background and anatomical match, were chosen by a “blinded”
investigator, and these 10 sections were used in the analysis. Occasionally, less than 10
sections were available per animal, and this is indicated in the figure legends. Similarly,
matched coronal sections encompassing the dorsomedial parvocellular PVN were also
analysed.
Immunocytochemistry for Fos protein
ICC using an affinity purified polyclonal antiserum raised in rabbit directed against the Fos
protein (Santa Cruz Biotech, Santa Cruz, CA) was performed on free-floating sections using
routine avidin–biotin methodology.15,59 Localization of antibody binding was visualized
using diaminobenzidine, as directed in the Vectastain Elite system (Vector, Burlingame,
CA).
Analysis and statistical considerations
Analysis of ISH results is described above. For ICC, quantitative analysis was restricted to
estimation of the number of cells expressing Fos protein in the hippocampal formation.
While the significant limitations of quantitative analysis using ICC are recognized, the
virtual all-or-none response of hippocampal c-fos signal in this study permitted evaluation of
the presence or absence of c-fos expression in the tissue. The significance of observed
quantitative differences among experimental groups was evaluated using one-way ANOVA
(PRISM software program, GraphPad), looking at the effects of treatment. Different brain
regions from each animal were analysed independently. Bonferroni’s post hoc test was used
if required. When two groups were compared, such as laboratory controls and stress-free
controls or laboratory controls and experimentals for a given region at a single time-point,
the unpaired Student t-test was used. P < 0.05 was considered significant and values are
presented as means with standard errors (S.E.M.).
RESULTS
C-fos expression, a marker of neuronal activation, is induced by hyperthermia, but not by
cold exposure, in the hippocampal formation
Neuronal activation was determined using molecular measures, i.e. induction of the
immediate-early gene c-fos, generally considered an adequate marker of cellular stimulation
in the CNS.31,42 This was correlated with behavioral and electrophysiological measures as
described below. Following hyperthermia, rapid expression of c-fos mRNA and of Fos
protein in hippocampal CA1 and CA3 was evident, using ISH and ICC, respectively. The
left panels of Fig. 1 demonstrate minimal c-fos mRNA signal in the hippocampus of a
laboratory control animal (Fig. 1A). Hyperthermia resulted in robust c-fos mRNA signal
over the hippocampus, but not over the PVN (Fig. 1C). The converse—expression of c-fos
in the PVN but not the hippocampus—was observed following cold exposure (Fig. 1E).
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Immunocytochemical analysis of Fos protein expression revealed individual Fos-
immunoreactive hippocampal neurons: Numerous hippocampal CA3 neurons expressed Fos
protein in response to hyperthermia (Fig. 1D), but not following cold challenge (Fig. 1F).
Little immediate-early gene expression, using either ISH or ICC, was observed in the
hippocampi of laboratory control animals (Fig. 1A, B). The 1-h time-point was found in
preliminary studies to coincide with peak hippocampal Fos expression in the immature rat.11
Further evidence for hyperthermia-related hippocampal neuronal stimulation was obtained
via behavioral analyses and depth bipolar electrode recording (Table 1, Fig. 4A, top two
tracings). Table 1 shows the duration and extent of hyperthermia in experimental and
hyperthermic control groups. After a 2- to 4-min latency, hyperthermia induced behavioral
manifestations consistent with limbic seizures in virtually all animals. These seizures
consisted of sudden arrest of all movement and a strong flexion spasm, usually accompanied
by oral automatisms, as described in detail previously and shown to correlate with seizure
discharges in hippocampal EEGs.5,18 Electrophysiological recordings were obtained from a
separate group of rats, as they involved electrode implantation and thus tissue invasion and
irritation. As shown in Fig. 4A, hyperthermia led to dramatic alteration of the low-
amplitude, non-rhythmic hippocampal activity (baseline, top left tracing). Repetitive semi-
rhythmic, high-voltage discharges (arrowheads, top right tracing) coincided with the
behavioral measures described above.
Corticotropin-releasing hormone messenger RNA in the hippocampal formation of the
immature rat is up-regulated by hyperthermia, but not by cold challenge
Expression of CRH mRNA was evident over the hippocampal formation of 10-day-old rats
(Fig. 2, top). The low-magnification autoradiograms show hybridization signal over the
pyramidal cell layer of CA1 and particularly of CA3a fields of Ammon’s horn, and over the
granule cell layer of the dentate gyrus (DG). Dark-field, higher magnification
photomicrographs of emulsion-dipped hippocampal sections reveal silver grains over
individual neurons (Fig. 2A). The location and morphology of these CRH-expressing
neurons are consistent with their identification as interneurons.59 After hyperthermia (Fig.
2C), signal intensity over CRH-expressing neurons was increased, compared with laboratory
controls (Fig. 2B). No change in CRH mRNA signal intensity was observed following cold
challenge (Fig. 2D).
Up-regulation of hippocampal corticotropin-releasing hormone gene expression by
hyperthermia and associated neuronal stimulation is robust and sustained
Sequential time-course analysis demonstrated significant enhancement of steady-state CRH
mRNA levels in all hippocampal fields investigated, that started within 1 h following
hyperthermia (see Fig. 3). Thus, for CA1, control values (0.040 ± 0.004 μCi/g) increased to
0.054 ± 0.003 μCi/g by 1 h, and peaked (0.058 ± 0.003 μCi/g) during the 4- to 8.5-h time-
points (P = 0.0004, ANOVA; P < 0.05, P < 0.01 and P < 0.001, laboratory controls vs 1, 4
and 8.5 h, respectively, Bonferroni’s post hoc test). Similar increases in CRH mRNA levels
were also found in the DG (P = 0.0001, F = 5.47) and CA3 (P = 0.0001, F = 5.95). The
enhancement of CRH gene expression was sustained: for the 8.5-h time-point, for example,
CRH mRNA levels were 151%, 154% and 143% of controls for the DG granule cell layer,
CA3 and CA1, respectively. The significant increase of CRH mRNA expression persisted in
all fields of the hippocampal formation for at least 24 h (Fig. 3). By 48 h (the duration of the
experiment), steady-state CRH mRNA levels were still significantly increased in the DG and
CA3, but not in CA1. It should be noted that a 50% increase in steady-state CRH mRNA
levels is highly significant physiologically.23,28,35 Indeed, adrenalectomy, with total
elimination of the negative feedback to CRH expression in the hypothalamus, results in a
similar enhancement of CRH mRNA levels (see Ref. 23 for discussion). In contrast to its
effects on hippocampal CRH expression, hyperthermia-related neuronal activation did not
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alter CRH mRNA levels in the PVN (Fig. 3, bottom panel, and see autoradiograms in Fig. 2,
bottom panel). ANOVA revealed no significant effect of treatment (P = 0.28, F = 1.33,
SStreatment = 0.26, d.f. = 5). Although visual inspection suggested a reduction of CRH
mRNA levels at the 1- and 48-h time-points, these trends did not reach statistical
significance (Bonferroni’s multiple comparison tests for 1 h: t = 1.631, P > 0.05; control vs
48 h: t = 1.304, P > 0.05).
Cold challenge does not influence corticotropin-releasing hormone messenger RNA levels
in the hippocampal formation
Based on the findings above and on the established time-course of the effects of cold
challenge on CRH mRNA levels, the 4-h time-point was chosen, to coincide with maximal
up-regulation of CRH mRNA in the hypothalamus.60 In contrast to the effects of
hyperthermia-related neuronal stimulation, cold challenge did not alter steady-state CRH
mRNA levels significantly in any hippocampal field. Specifically, CRH mRNA levels in
CA1 were 0.040 ± 0.004 μCi/g in laboratory controls and 0.046 ± 0.004 μCi/g in the
experimental group (P > 0.05, Student’s t-test). The autoradiograms in Fig. 2 (top) illustrate
that CRH mRNA signal over the hippocampus of cold challenged animals was not higher
than that over the hippocampus from laboratory controls, and a semi-quantitative analysis of
hippocampal CRH mRNA expression is shown in Table 2 (the values for total hippocampus
are a mean of values obtained separately for CA1, CA3 and the DG). In contrast, activation
of the neuroendocrine stress axis by cold (as also evident from plasma corticosterone levels;
Table 3) increased CRH mRNA levels in the PVN (Fig. 2, bottom), as shown before.
Neuronal stimulation is required for enhancement of corticotropin-releasing hormone
gene expression in the hippocampus
The requirement for robust hippocampal neuronal activation by a given stimulus to
influence CRH gene expression in this region is further illustrated in Fig. 4. Administration
of sodium pentobarbital, a blocker of polysynaptic neurotransmission via interaction with
the GABAA receptor, eliminated the behavioral, electrophysiological and molecular (c-fos
expression; not shown) parameters of hippocampal neuronal stimulation: It suppressed both
behavioral seizures (Table 1) and the epileptic discharges recorded from the hippocampus,
as shown in Fig. 4A: the top tracings demonstrate the electrophysiological recordings from
depth bipolar electrodes placed in the dorsal hippocampus of immature rats. Hyperthermia
induced intense neuronal stimulation, i.e. synchronous rhythmic EEG discharges5,14,18 that
were accompanied by behavioral seizures.18,56 The bottom tracings show that administration
of the short-acting barbiturate, pentobarbital, prior to induction of hyperthermia eliminated
the electrographic evidence of neuronal stimulation. Pentobarbital did not alter the duration
or the intensity (maximal temperature) of the hyperthermia per se (Table 1). However, the
compound eliminated all three parameters of hippocampal neuronal stimulation, as well as
the hyperthermia-induced up-regulation of CRH mRNA levels (Fig. 4B). For example, in
CA3, at the time of peak hyperthermia effect on CRH expression (8.5 h), CRH mRNA
levels were 0.041 ± 0.004 μCi/g in normothermic controls, 0.064 ± 0.003 μCi/g in the
experimental group and 0.041 ± 0.002 μCi/g in pentobarbital-treated hyperthermic controls
(P < 0.001 vs the experimental group). The suppression of hyperthermia-induced up-
regulation of CRH expression by pentobarbital was similar in all three fields of the
hippocampal formation, and these values are combined in Fig. 4B.
DISCUSSION
The major findings of these experiments are: (i) hippocampal CRH mRNA levels were
enhanced by an elevation of core temperature that resulted in neuronal stimulation and
immediate-early gene expression; (ii) induction of hippocampal CRH gene expression
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required neuronal stimulation and was abolished by barbiturate administration; (iii) whereas
cold, a powerful activator of the neuroendocrine stress response in the immature rat,
enhanced CRH mRNA levels in the PVN, hippocampal CRH expression was unaffected.
Taken together, these results demonstrate that CRH expression is differentially regulated by
physiologically relevant stimuli, that may lead to sustained up-regulation of the peptide’s
mRNA levels. Furthermore, regulation of hippocampal CRH expression is independent of
that in the hypothalamus and is influenced by hippocampal neuronal stimulation.
CRH is abundantly expressed in CNS regions shown to participate in the neuroendocrine
and behavioral responses to stress. For example, the role of CRH, released from terminals of
hypothalamic PVN neurons, in mediating the neuroendocrine stress response has been
established,47,57,60 and local release of CRH in the ACe, influencing stress-induced
behaviors, has been demonstrated.40,54 Consistent with the functional role of hypothalamic
and amygdala CRH in modulating stress responses, up-regulation of CRH expression in
these two regions by challenges that activate the neuroendocrine stress response has been
documented.23,29 Teleologically, this mechanism for regulation of CRH levels should be
advantageous, resulting in larger releasable pools of CRH upon subsequent challenges.
In the hippocampus, the presence of CRH-expressing inter-neurons has been documented in
both the mature and developing rat,41,48,53,59 but the physiological functions of the peptide
and the regulation of CRH levels at hippocampal synapses have not been fully established.
Specifically, whether hippocampal CRH participates in the neuroendocrine stress response
has been questioned.38 Here, we show that a prototypic physiological challenge that
activates the hypothalamic–pituitary–adrenal axis (cold exposure of the immature rat) does
not alter CRH expression in the hippocampus. This is in contrast to up-regulation of CRH in
the PVN (Fig. 2, bottom panels).
If challenges that activate the hypothalamic–pituitary–adrenal axis do not up-regulate
hippocampal CRH expression, what mechanisms control the peptide’s levels in this region?
Up-regulation of CRH mRNA in some hippocampal fields of the mature rat has been shown
following kindling52 or kainate administration.44 These experimental manipulations share
intense excitation of hippocampal neurons and are associated with activation of numerous
genes.12,27,46 In the current studies, moderate hyperthermia (within the physiological range
seen in febrile immature humans) led to motor stimulation and to electrophysiological
activation of immature rat hippocampal neurons.5,14,56 Taken together with the studies
mentioned above, this may be interpreted to indicate that intense stimulation of hippocampal
neurons (demonstrated in the current study by both c-fos induction and EEG) leads to
enhanced CRH expression in this region.
Activity-dependent regulation of CRH expression in the hippocampus is consistent with
emerging information regarding the putative physiological functions of this peptide in the
hippocampal formation. Application of CRH has been shown to enhance hippocampal
pyramidal cell firing1 and synaptic efficacy.32 More recently, in vitro studies have shown
that CRH modulates glutamatergic mechanisms to increase excitatory neurotransmission in
the hippocampal circuit.6,25 Thus, under physiological circumstances, release of CRH may
modulate hippocampal neurotransmission, augmenting glutamate-mediated alterations of
hippocampal function. This may influence both normal hippocampal processes such as long-
term potentiation and, when excessive, may promote abnormal excitation1,6,25 and
excitotoxicity.9,36,37
The neuroanatomical basis for the influence of CRH on hippocampal neurotransmission has
been explored. Previous work from the authors’ laboratory has demonstrated a substantial
CRH-expressing interneuronal population in the hippocampal formation of the immature
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rat.59 These cells are located primarily within, and bordering on, the pyramidal cell layer of
CA3 and CA1. The majority of these neurons, co-expressing CRH and parvalbumin, were
identified as basket and axo-axonic (chandelier) cells, synapsing on somata and axon initial
segments of pyramidal cells, respectively.59 They are thus strategically positioned to
influence pyramidal cell firing. In addition, CRH receptors, particularly corticotropin-
releasing factor-1, shown to mediate the excitation-promoting actions of CRH,4 are
abundantly expressed in hippocampal pyramidal cells.2,13,15 These data support the notion
that, in the hippocampus, CRH modulates synaptic neurotransmission; in turn, expression of
the CRH gene is controlled by hippocampal circuit activation.
The requirement for stimulation of hippocampal neurons4,14,56 for up-regulation of
hippocampal CRH expression, suggested in the current study, is further illustrated by the
effects of barbiturates: hyperthermia-induced hippocampal CRH mRNA expression was
abolished (in CA1) or attenuated (in CA3) by barbiturate pretreatment, providing clues for
the mechanisms for CRH mRNA activation in the hippocampus: Pentobarbital interferes
with polysynaptic neurotransmission by modulating GABAA receptors. Indeed, it eliminated
the hyperthermia-induced intense hippocampal neuronal stimulation, as evident from
behavioral and electrophysiological criteria (Fig. 4A, and Refs 4, 14, 18 and 56). Thus, the
effect of the barbiturate is consistent with the notion that neuronal stimulation, distinct from
any hormonal or autonomic consequences of elevated core temperature, is required for
hyperthermia-induced up-regulation of hippocampal CRH mRNA expression.
The current study also highlights the region-specific regulation of CRH expression.
Hypothalamic CRH mediates the hormonal stress response, and CRH mRNA levels in the
PVN are up-regulated by numerous acute physiological stressors.35,58 Accordingly, cold
challenge activated both neuroendocrine responses (such as enhanced plasma corticosterone;
Table 3) and CRH expression in the PVN.23,60 However, this physiological, neuroendocrine
challenge did not influence CRH mRNA levels in any hippocampal region.
In the immature rat, prolonged separation from the mother can augment neuroendocrine
responses3,34,51 and immediate-early gene expression51 to physiological challenges. To
control for potential effects of maternal separation on hypothalamic51 and hippocampal
CRH gene expression, laboratory controls were employed, that were separated from their
mothers for the same duration as were animals subjected to hyperthermia or cold challenge.
Therefore, the enhanced CRH mRNA levels in hippocampal neurons stimulated by
hyperthermia, compared with CRH mRNA in laboratory controls, cannot be due to effects of
maternal separation.
The up-regulation of hippocampal CRH mRNA levels noted in the current study was quite
sustained, lasting for 24–48 h. The methods used here cannot distinguish with certainty
whether this fact resulted from prolonged effects of the intense, hyperthermia-induced
neuronal stimulation, or reflect the relatively long half-life of CRH mRNA. Using specific
probes directed against heteronuclear (unedited) CRH RNA, our6 and other17 groups have
shown a rapid activation of the CRH gene in the immature rat hypothalamus after
appropriate challenges. The half-life of heteronuclear CRH RNA is short, permitting
resolution of gene activation and inactivation in the range of minutes.6,17 However, steady-
state CRH mRNA levels, with their slow turnover, may not fully reflect the kinetics of CRH
gene activation in the immature rat.
It may be interesting to compare the results of the current study to the few reports about the
regulation of CRH expression in the hippocampus of the adult rat. Of note, in mature
experimental animals, levels of hippocampal CRH expression, unlike those in the
hypothalamus,35,58 have not been found to correlate with stress.38 It may be argued that the
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threshold to induction of hippocampal CRH expression is higher than that required for up-
regulation of the CRH gene in the PVN. Indeed, the presence of differential thresholds for
the effects of a given stimulus on CRH function has recently been demonstrated.55
However, the cold challenge employed here60 is a powerful activator of the neuroendocrine
stress response, resulting in markedly elevated plasma corticosterone3,23,60 (Table 3).
Therefore, the absence of an effect of cold challenge on hippocampal CRH expression,
combined with the rapid and prolonged up-regulation of CRH mRNA levels in the
hippocampus by hyperthermia, indicates that enhanced CRH gene transcription in the
hippocampus requires factors other than provocation of physiological, hormonal responses
to stress.
Finally, potential interactions between hippocampal and hypothalamic CRH expression
should be noted: the hippocampus is recognized to have negative effects on hypothalamic
parvocellular neurons expressing CRH.24 Therefore, it could be argued that decreasing
hippocampal neuronal activity by pentobarbital may disinhibit CRH expression in the PVN.
However, CRH mRNA levels in the PVN were not changed by pentobarbital administration
alone (0.56 ± 0.19 vs 0.42 ± 0.05 μCi/g in vehicle-injected controls; P = 0.37).
CONCLUSION
In summary, this study demonstrates a robust and sustained stimulus-specific up-regulation
of CRH gene expression in the hippocampus of the immature rat. Given the established and
emerging functions of hippocampal CRH, these findings suggest that modulation of
hippocampal CRH levels may be a physiological mechanism for influencing hippocampal
neurotransmission.
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Fig. 1.
Differential induction of hippocampal c-fos mRNA and Fos protein expression by two
distinct physiological stimuli. Nine- or ten-day-old rats were killed 1 h following
hyperthermia (C, D) or cold stress (E, F) and compared with laboratory controls (A, B). Film
autoradiograms following ISH for detection of c-fos mRNA are shown in A, C and E. Little
c-fos mRNA signal was observed in animals maintained in the laboratory for 2–4 h (A).
Hyperthermia induced c-fos mRNA expression in the hippocampus (Hippo) and piriform
cortex (PirCtx; C). Following cold exposure, c-fos mRNA was expressed in the PVN and
piriform cortex, but not in the hippocampus (E). Fos protein immunoreactivity was evident
in individual hippocampal neurons following hyperthermia (D), but not after cold (F) or in
laboratory controls (B). Scale bar in F = 2 mm (A, C, E), 0.4 mm (B, D, F).
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Fig. 2.
Differential CRH mRNA expression in the hippocampus and PVN of immature rats. Top:
CRH mRNA signal was detected using ISH in coronal sections through the hippocampus of
10-day-old rats. (A) Dark-field photomicrograph of an emulsion-dipped section, showing
silver grains over a CRH mRNA-expressing neuron (arrow) located at the edge of CA3
stratum pyramidale (s.p.). (B–D) Representative film autoradiograms demonstrating CRH
mRNA expression in the hippocampus of laboratory control rats (B), compared with those
subjected to hyperthermia (C) or to cold exposure (D). Hyperthermia resulted in significant
increases of CRH mRNA hybridization signal over the entire hippocampal formation (CA1
and CA3 subfields, and the DG). Magnifications: × 200 (A), × 15 (B–D). Bottom:
representative photomicrographs of CRH mRNA expression in the PVN, as influenced by
cold challenge (Cold), hyperthermia (HT) or pentobarbital (Pb) administration. Under both
stress-free and laboratory control conditions (see Experimental Procedures), CRH mRNA
signal was robust in the parvicellular division of the PVN. These levels were markedly
enhanced 4 h after cold. In contrast, CRH mRNA levels were not appreciably altered 4, 8.5
or 24 h after hyperthermia. In addition, this transcript was not influenced by barbiturate
administration. Magnification: × 9.
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Fig. 3.
Time-course and regional distribution of the effects of neuronal activation on CRH mRNA
expression in the hippocampal formation and PVN. Semi-quantitative analysis of CRH
mRNA hybridization signal over the DG and hippocampal CA3 or CA1, as well as the PVN,
at specific time-points following hyperthermia. Sections were subjected to ISH and analysis
as described in the Experimental Procedures. For hippocampal CRH expression (top three
panels), ANOVA revealed significant effects of hyperthermia (CA1: P = 0.0004, F = 4.84,
d.f. = 5; CA3: P = 0.0001, F = 5.95; DG: P = 0.0001, F = 5.47). Bonferroni’s post hoc test
analysis revealed a significant increase (*P < 0.01; **P < 0.05) of CRH mRNA levels at all
time-points (DG, CA3) or for 24 h (CA1) relative to laboratory control levels. Each bar
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represents the mean ± S.E.M. of six to 10 matched sections from each of at least three rat
pups, providing a sample size of 18–30. Bottom panel: in contrast to the hippocampus,
hypothalamic CRH mRNA expression was not significantly influenced by hyperthermia
(ANOVA for effect of treatment revealed P > 0.05). Also, although a trend for reduced CRH
mRNA levels may be apparent for the 1- and 48-h time-points, it did not reach statistical
significance (Bonferroni’s multiple comparison tests).
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Fig. 4.
Hippocampal electrophysiological activation and up-regulation of CRH mRNA expression
are abolished by barbiturate pre-administration. (A) Representative EEG recordings
obtained via bipolar depth electrodes from the hippocampi of immature rats. Top left: the
baseline theta-frequency, low-amplitude hippocampal EEG activity. The arrow shows a
movement artifact. Top right: hyperthermia induced repetitive high-amplitude semi-
rhythmic discharges (arrowheads), typical of electrographic seizures involving the
hippocampus. The animal was motionless during these events. Pentobarbital (Pentobarb; 30
mg/kg, i.p.), given immediately prior to the onset of hyperthermia, altered the baseline
activity by eliminating the theta rhythm and decreasing the EEG amplitude (left, bottom
tracing). Importantly, when pentobarbital-treated animals were subjected to hyperthermia,
electrographic seizures were not observed on the hippocampal EEG (right, bottom tracing),
and no behavioral seizures occurred. Vertical scale: 50 μV; horizontal: 1 s. (B) Semi-
quantitative analysis showing the effects of hyperthermia and barbiturates (pentobarbital,
Pb) on CRH mRNA levels in the hippocampus. Bars represent CRH mRNA hybridization
signal over the hippocampal formation (combined CA1, CA3 and DG) 8.5 h after
hyperthermia alone or with pentobarbital pretreatment. Hyperthermia resulted in a
significant increase relative to both the control and the pentobarbital-treated rats. *P < 0.05
(Student’s t-test), comparing hyperthermics to the laboratory controls and the hyperthermic
(pentobarbital-treated) controls. Hippocampal CRH mRNA levels of animals injected with
pentobarbital alone did not differ significantly from those who received an i.p. injection of
vehicle (88 ± 5.5%; P = 0.52, Student’s t-test). Samples are the mean ± S.E.M. of a total of
30 matched sections from at least three animals per group.
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Table 2
Stimulus-specific increases of hippocampal corticotropin-releasing hormone messenger RNA expression
Treatment paradigm
Control Hyperthermia Cold challenge
CRH mRNA levels 100 ± 4.8 148 ± 4.5* 97 ± 4.6
*
Relative levels of CRH mRNA hybridization signal over the hippocampal formation (combined DG, CA3 and CA1) 4 h following hyperthermia
or cold challenge. CRH mRNA expression was selectively up-regulated following hyperthermia (Student’s t-test, comparing hyperthermia to
laboratory controls, P < 0.001), but not following cold challenge. Samples are the mean ± S.E.M. of a total of 23–40 matched sections from at least
three rats per group, and values are expressed as the percentage of control levels. Note: CRH mRNA levels of stress-free and laboratory controls
did not differ, and the groups were combined.
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Ta
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f p
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 c
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6
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.1
3
6.
58
*  
± 
0.
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 ±
 0
.0
8
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 m
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 c
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. S
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nt
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w
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an
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ci
lit
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 la
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to
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l 3
5)
.
* S
ig
ni
fic
an
tly
 d
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m
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 c
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 (P
 <
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